Paper10467366
Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
Kokoris MS and 3 others. Gene Ther, 1999. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Papers, record 10467366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10467366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Therapy | Major topic |
| Glioma | Major topic |
| Herpesvirus 1, Human | Major topic |
| Thymidine Kinase | Major topic |
| Acyclovir | |
| Amino Acid Sequence | |
| Animals | |
| Ganciclovir | |
| Gene Transfer Techniques | |
| Genetic Vectors | |
| Mice | |
| Mice, Nude | |
| Models, Molecular | |
| Molecular Sequence Data | |
| Mutation | |
| Neoplasm Transplantation | |
| Prodrugs | |
| Rats | |
| Transfection | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 ES07033 | NIEHS NIH HHS | United States | P30ES007033 | PubMed and NIH |
Source NIH RePORTER
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7548276 | The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. | Hum Gene Ther | 1995 | https://conductscience.org/library/papers/7548276 | PubMed |
| 2 | 7621241 | Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. | Cancer Gene Ther | 1994 | https://conductscience.org/library/papers/7621241 | PubMed |
| 3 | 2273392 | Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation. | J Gen Virol | 1990 | https://conductscience.org/library/papers/2273392 | PubMed |
| 4 | 8527482 | Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. | Hum Gene Ther | 1995 | https://conductscience.org/library/papers/8527482 | PubMed |
| 5 | 6306664 | 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6306664 | PubMed |
| 6 | 1317968 | In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. | Science | 1992 | https://conductscience.org/library/papers/1317968 | PubMed |
| 7 | 8221662 | The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. | Cancer Res | 1993 | https://conductscience.org/library/papers/8221662 | PubMed |
| 8 | 7831805 | Expression of a Tat-inducible herpes simplex virus-thymidine kinase gene protects acyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription. | Virology | 1995 | https://conductscience.org/library/papers/7831805 | PubMed |
| 9 | 8018748 | Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. | Hum Gene Ther | 1994 | https://conductscience.org/library/papers/8018748 | PubMed |
| 10 | 3093688 | Glial culture on artificial capillaries: electron microscopic comparisons of C6 rat glioma cells and rat astroglia. | J Neurosci Res | 1986 | https://conductscience.org/library/papers/3093688 | PubMed |
| 11 | 8058777 | Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8058777 | PubMed |
| 12 | 8159705 | Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8159705 | PubMed |
| 13 | 1335091 | Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. | J Neurosci Res | 1992 | https://conductscience.org/library/papers/1335091 | PubMed |
| 14 | 2299679 | Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. | J Natl Cancer Inst | 1990 | https://conductscience.org/library/papers/2299679 | PubMed |
| 15 | 1318167 | Characteristics of C6 glioma cells overexpressing a gap junction protein. | Cell Mol Neurobiol | 1992 | https://conductscience.org/library/papers/1318167 | PubMed |
| 16 | 9095411 | A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients. | Hum Gene Ther | 1997 | https://conductscience.org/library/papers/9095411 | PubMed |
| 17 | 6248551 | Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. | J Biol Chem | 1980 | https://conductscience.org/library/papers/6248551 | PubMed |
| 18 | 2553730 | Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2553730 | PubMed |
| 19 | 9498487 | Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. | J Natl Cancer Inst | 1998 | https://conductscience.org/library/papers/9498487 | PubMed |
| 20 | 1313013 | Permissible amino acid substitutions within the putative nucleoside binding site of herpes simplex virus type 1 encoded thymidine kinase established by random sequence mutagenesis [corrected]. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1313013 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41809368 | Intravenous oncolytic vaccinia expressing transgenes for enhanced safety, inhibition of shedding, imaging, and systemic cancer immunotherapy. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/41809368 | PubMed |
| 35402634 | Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles. | Mol Ther Methods Clin Dev | 2022 | https://conductscience.org/library/papers/35402634 | PubMed |
| 25824605 | Liver-targeted gene therapy: Approaches and challenges. | Liver Transpl | 2015 | https://conductscience.org/library/papers/25824605 | PubMed |
| 24231389 | Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity. | DNA Repair (Amst) | 2013 | https://conductscience.org/library/papers/24231389 | PubMed |
| 22384805 | Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy. | Curr Gene Ther | 2012 | https://conductscience.org/library/papers/22384805 | PubMed |
| 20020177 | Construction of a ganciclovir-sensitive lentiviral vector to assess the influence of angiopoietin-3 and soluble Tie2 on glioma growth. | J Neurooncol | 2010 | https://conductscience.org/library/papers/20020177 | PubMed |
| 19763147 | Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo. | Cancer Gene Ther | 2010 | https://conductscience.org/library/papers/19763147 | PubMed |
| 18949076 | The role of herpes simplex virus-1 thymidine kinase alanine 168 in substrate specificity. | Open Biochem J | 2008 | https://conductscience.org/library/papers/18949076 | PubMed |
| 18291415 | Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine. | J Mol Biol | 2008 | https://conductscience.org/library/papers/18291415 | PubMed |
| 17853921 | Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model. | Cancer Gene Ther | 2007 | https://conductscience.org/library/papers/17853921 | PubMed |
| 17658449 | A method for quantification of nucleotides and nucleotide analogues in thymidine kinase assays using lanthanum phosphate coprecipitation. | Anal Biochem | 2007 | https://conductscience.org/library/papers/17658449 | PubMed |
| 17581598 | Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs. | Gene Ther | 2007 | https://conductscience.org/library/papers/17581598 | PubMed |
| 16964432 | A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy. | Int J Mol Med | 2006 | https://conductscience.org/library/papers/16964432 | PubMed |
| 16885999 | Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants. | Gene Ther | 2007 | https://conductscience.org/library/papers/16885999 | PubMed |
| 16810197 | A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing. | Gene Ther | 2006 | https://conductscience.org/library/papers/16810197 | PubMed |
| 15818381 | Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin. | Cancer Gene Ther | 2005 | https://conductscience.org/library/papers/15818381 | PubMed |
| 15729368 | VP22-mediated intercellular transport for suicide gene therapy under oxic and hypoxic conditions. | Gene Ther | 2005 | https://conductscience.org/library/papers/15729368 | PubMed |
| 15592447 | Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. | Cancer Gene Ther | 2005 | https://conductscience.org/library/papers/15592447 | PubMed |
| 15483667 | Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase. | Gene Ther | 2005 | https://conductscience.org/library/papers/15483667 | PubMed |
| 12869307 | Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging. | Neoplasia | 2003 | https://conductscience.org/library/papers/12869307 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10467366
GET https://conductscience.org/api/papers/v1/10467366/references?page=2